Clinuvel Pharmaceuticals

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Trading Performance

Momentum Oscillator

Score

-0.8

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 28 17.0 0.50% 0.93% 12.1% -3.6% 115.9%
SHORT 27 10.6 0.15% 0.17% 3.7% -3.4% -64.2%

Summary

Technical Analysis

Clinuvel Pharmaceuticals (CUV.AX)


Indicator:

MOMENTUM


Last Signal:

BULLISH


Trading: HOLD @ $36.49
Signal Strength: MEDIUM
Recommendation:

Clinuvel Pharmaceuticals (ASX:CUV) currently has positive momentum of 2.81. This means the current price is greater than the price 14 days ago and therefore gaining momentum.

Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to detect the speed of movement & give an early signal for a potential movement. By understanding the rate at which the price is moving in respect to the stocks historical trades, enables positions to be set in place based on changes in the speed of movement


Momentum measures the rate of change in closing prices and is used to detect trend weakness and likely reversal points. It is often underrated because of its simplicity. High Momentum readings (positive or negative) occur when a trend is at its strongest. Lower readings are found at the start and end of trends. Overbought and oversold levels are set separately for each security based on the performance of the indicator over past cycles.

Calculation: Momentum Oscillator (MOM):
1) Closing Price [today] - Closing Price [n days ago];

PROFILE: Clinuvel Pharmaceuticals (CUV.AX)


Stock Exchange: ASX
Company: Clinuvel Pharmaceuticals
Ticker Codes: | CUV.AX | ASX:CUV |

About Clinuvel Pharmaceuticals (ASX:CUV):

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of a range of severe skin disorders. Its lead drug compound is SCENESSE, a medicinal photoprotective and repigmentation drug that has completed Phase II and III trials in the United States and Europe, which is used for the prevention of phototoxicity in adults with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue that acts as a potent skin protectant; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. It has operations in Europe, the United States, and Singapore. The company is headquartered in Melbourne, Australia.

Top 10:

Momentum Oscillator

Download
Company Close Change(%) Volume Value Signal
BRN Brainchip Holdings 0.08 11.6 9,040,170 0.03 BULLISH
SLR Silver Lake Resources 0.94 8.7 10,759,307 0.14 BULLISH
NAN Nanosonics 5.36 8.7 2,348,894 0.98 BULLISH
RAP Resapp Health 0.2 8.3 2,913,547 0.05 BULLISH
OMH OM Holdings 0.92 5.8 56,591 0.15 BULLISH
BWX BWX 2.23 5.2 695,496 0.62 BULLISH
IRI Integrated Research 3.15 5 286,098 0.43 BULLISH
CWY Cleanaway Waste Management 2.37 4.9 5,497,121 0.13 BULLISH
PRU Perseus Mining 0.52 4 9,497,712 0.05 BULLISH
NHF NIB 7.46 3.9 1,058,099 0.78 BULLISH